RxDoctor Payments Data

Doris Hastey, APRN

Psychiatric/Mental Health · Mena, ARNPI 1790201820

Payments from drug & device makers

$2,161in general payments, 2019–2025

Across 155 payments — averaging $13.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$365
  • Alkermes, Inc.$91
  • Axsome Therapeutics, Inc.$67
  • Abbott$59
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$58
  • plus $178 from 7 others

What the payments were for

  • Food & beverage$2,161100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,161 in reported general payments places this provider in the 70th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$20,420
Medicare patients
104
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl93$142,359
Invega SustennaPaliperidone Palmitate35$123,781
RexultiBrexpiprazole61$107,596
Abilify MaintenaAripiprazole21$59,964
AuvelityDextromethorphan Hbr/Bupropion19$19,333
TrintellixVortioxetine Hydrobromide26$16,864
Aripiprazole176$12,302
Lurasidone Hcl32$7,754
Clozapine24$3,027
Quetiapine Fumarate191$2,874
Prazosin Hcl133$2,731
Buspirone Hcl231$2,600
Duloxetine Hcl116$1,970
Divalproex Sodium105$1,966
Clonazepam234$1,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$365$167,56082 claims
AbbVieVraylar$1,344$142,35993 claims
Axsome Therapeutics, Inc.Auvelity$67$19,33319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Mena

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →